CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
about
Biomarkers in Alzheimer's disease.Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.Neurochemical biomarkers in Alzheimer's disease and related disorders.Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's diseaseCSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's diseaseAssessment of cognition in early dementia.The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjectsCSF biomarkers for amyloid and tau pathology in Alzheimer's disease.CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.Neuroimaging, biomarkers, and management of dementia with lewy bodies.Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical CorrelatesBiological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel.Generation of Rabbit Monoclonal Antibody to Amyloid-β38 (Aβ38): Increased Plasma Aβ38 Levels in Down Syndrome.The soluble transcobalamin receptor (sCD320) is present in cerebrospinal fluid and correlates to dementia-related biomarkers tau proteins and amyloid-beta.Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations.Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.
P2860
Q35113795-14A3182F-F710-4928-B833-B2A4FBA216ACQ35166684-4549F48D-5AE8-49A6-BB17-7697AC81D5BCQ36366891-4BEDC2A7-9376-4B6E-887A-CB507B5F248BQ36383749-76F35EEE-EE47-4B0E-AF99-3635DE239519Q36639655-02115869-651C-4354-B81D-6E20834D4526Q36718213-76F39428-5C4C-4288-8823-B172DB19A8CEQ36733293-684EF0EC-780E-45CC-AC3B-1393E74CCC0EQ36806654-02F6AF00-CBEE-4717-A384-A7DB936D14A8Q37953330-6FC9C1F7-5188-4F8F-BF4A-35E83D0FA1A4Q38012590-113A9BDC-254A-4BCC-8AD3-7E7C4DC993BBQ38151095-A95211D0-1E38-4ED3-A9E2-E8EE4A05DC32Q38585712-5D7333F5-FAB3-45CB-83B0-292577AE755BQ38603309-DE39448D-5D2B-4893-B967-12684E6621F3Q39098473-3C28EB64-045D-4895-B28E-A9574073E736Q40506355-5137EEDF-63BA-4430-87BC-46922B509866Q40702846-E7E377C5-7F42-46CF-BBB1-E66EC5B985DDQ45903959-F9441255-6792-43E5-A382-8B5222DF7CC9Q47996302-FC76F011-5C72-4BB5-BE17-91327C7B3787
P2860
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@en
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@nl
type
label
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@en
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@nl
prefLabel
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@en
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@nl
P50
P356
P1476
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
@en
P2093
Ezra Mulugeta
Ragnhild Skogseth
P304
P356
10.1136/JNNP.2009.199398
P407
P577
2010-11-03T00:00:00Z